Search clinical trials for: Phase III outcome trial

Total 76877 results

Samsung Medical Center

Completed

Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer

Gastric Cancer | Metastases

Korea, Republic of
Heidelberg University

Completed

Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly (Methusalem)

Glioblastoma | Anaplastic Astrocytoma

Germany, Switzerland
Korean South West Oncology Group

Unknown

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

Carcinoma, Non-Small-Cell Lung | Carcinoma, Large Cell | Carcinoma, Squamous

Korea, Republic of
King Faisal Specialist Hospital & Research Center

Unknown

Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca (GORG-002)

Breast Cancer

Saudi Arabia, Kuwait, United Arab Emirates
Samsung Medical Center

Completed

Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma

Gastric Cancer | Surgery

Korea, Republic of
TTY Biopharm

Terminated

Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve

Carcinoma, Hepatocellular

Taiwan
Clinuvel Pharmaceuticals Limited

Completed

Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

Polymorphic Light Eruption (PLE)

Austria, Australia, United Kingdom
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management

Marijuana Dependence

United States
New Mexico Cancer Care Alliance

Completed

A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

Supportive | Ill-defined Sites

United States
Eli Lilly and Company

Completed

Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC

Metastatic Breast Cancer (MBC)

Italy
ALK-Abelló A/S

Completed

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Grass Pollen Allergy

Denmark
Ministry of Health, Labour and Welfare, Japan

Unknown

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Neoplasms | Carcinoma | Carcinoma, Hepatocellular | Liver Neoplasms | Advanced Hepatocellular Carcinoma

Japan
Ortho Biotech Products, L.P.

Terminated

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

Quality of Life | Breast Neoplasms | Anemia | Hemoglobins | Chemotherapy, Adjuvant
King Faisal Specialist Hospital & Research Center

Suspended

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Memorial Sloan Kettering Cancer Center

Completed

Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial

Cancer

United States
Janssen Pharmaceutical K.K.

Completed

Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics

Pain, Intractable
Karolinska Institutet
Merck Sharp & Dohme LLC

Completed

Nordic Adjuvant IFN Melanoma Trial

Melanoma | Adjuvant Therapy

Sweden
Eli Lilly and Company

Completed

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Belgium
National Cancer Center, Korea
Jeil Pharmaceutical Co., Ltd.

Unknown

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Advanced Non-Small Cell Lung Cancer

Korea, Republic of
Ineos Healthcare Limited

Terminated

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate

Chronic Kidney Failure

United States, Canada, Australia, New Zealand, Brazil, France, Germany, Malta, Poland, South Africa, Spain
Swedish Medical Center
Pfizer

Completed

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Adenocarcinoma | Lung Cancer

United States
Universidad Complutense de Madrid

Unknown

Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers

Diabetic Foot Ulcers | Diabetic Foot | Osteomyelitis

Spain
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center; Merck KGaA, Darmstadt, Germany; US Department... and other collaborators

Completed

Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

Carcinoma, Small Cell Lung
Bristol-Myers Squibb

Completed

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

Rheumatoid Arthritis

United States, Mexico
Pierre Fabre Medicament
Bristol-Myers Squibb

Completed

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Bladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial Tract

Canada
Eli Lilly and Company

Completed

A Phase III Trial For Patients With Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms | Cancer of the Breast

United States, Argentina, Australia, Brazil, Korea, Republic of, Mexico, Puerto Rico, Taiwan
Ventracor
International Center for Health Outcomes and Innovation Research

Unknown

VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial

Cardiomyopathies | End-stage Heart Failure

United States
CONKO-Studiengruppe
Sanofi; Amgen; medac GmbH

Approved for marketing

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Pancreatic Cancer
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer

Breast Cancer

Greece
Rigel Pharmaceuticals

Completed

Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)

Rheumatoid Arthritis

United States, Mexico
Sanofi

Completed

Obese Patients With Type 2 Diabetes (RIO-Diabetes)

Obesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in Diabetes

United States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
Marilia Medicine School

Completed

Trial Comparing Best Supportive Care to Aloe Vera Gel

Radiation Dermatitis

Brazil
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Gilead Sciences; Hoffmann-La... and other collaborators

Terminated

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

HIV Infections | HIV-Associated Lipodystrophy

Australia
Sanofi

Completed

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder (CALYPSO)

Depressive Disorder | Major Depression

France, Poland, Romania, Russian Federation, Bulgaria, Serbia, Slovakia, Czech Republic, Mexico, Argentina, Croatia, Finland, South Africa
Abbott

Completed

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

HIV Infections

United States, Canada, Puerto Rico, Switzerland, France, Germany, United Kingdom, Australia, Brazil, Austria, Denmark, Poland, South Africa, Spain
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
SK Chemicals Co., Ltd.

Completed

Phase III Trial of Febuxostat in Korea Gout Patients

Gout
Fudan University

Unknown

Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung

China
Novartis

Terminated

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Proliferative Diabetic Retinopathy

Switzerland
Norgine

Completed

A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

Colonoscopy

Germany
Advanz Pharma
Astellas Pharma US, Inc.

Completed

Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation (ACT I)

Atrial Fibrillation

United States, Canada, Sweden, Denmark
National Institute of Allergy and Infectious Diseases...

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Melanoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Herpes Simplex

United States
National Cancer Institute (NCI)

Completed

Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
National Cancer Institute (NCI)

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses | Candidiasis | Fungemia | Aspergillosis

United States
National Cancer Institute (NCI)

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Sepsis | Hematologic Diseases | Breast Neoplasms | Neutropenia | Fever

United States
National Cancer Institute (NCI)

Completed

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

Osteosarcoma

United States
National Cancer Institute (NCI)

Completed

Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

Breast Cancer

Greece

3

Subscribe